This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

TESARO To Participate In Several Upcoming Investor Conferences

WALTHAM, Mass., Aug. 30, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical company, announced that Lonnie Moulder, CEO of TESARO, and Mary Lynne Hedley, Ph.D., President of TESARO, will participate in several upcoming investor conferences during the month of September, including:

  • Citi's 8th Annual Biotech Day at the Mandarin Oriental Hotel in Boston on Wednesday, September 4, 2013  
  • The JMP Securities Biotech Day at the Langham Hotel in Boston on Friday, September 6, 2013 at 11:30 a.m. EDT.  
  • Baird's 2013 Health Care Conference at The New York Palace Hotel in New York City on Tuesday, September 10, 2013 at 1:45 p.m. EDT. A live webcast will be available by visiting the Investors section of the TESARO website at www.tesarobio.com . An archived replay of the webcast will be available on the Company's website for 14 days after the conference. The Company will also participate on a panel titled "Oncology Drug Pricing – Positioning for Success in a Rapidly Changing Reimbursement Landscape" on Wednesday, September 11, 2013 at 12:10 p.m. EDT.  
  • The Morgan Stanley Global Healthcare Conference at the Grand Hyatt in New York City on Wednesday, September 11, 2013 at 1:30 p.m. EDT. A live webcast will be available by visiting the Investors section of the TESARO website at www.tesarobio.com . An archived replay of the webcast will be available on the Company's website for 14 days after the conference.

About TESARO

TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.

CONTACT: Jennifer Davis
         Sr. Director, Corporate Development & Investor Relations
         1.781.325.1116
         jdavis@tesarobio.com

TESARO, Inc. Logo

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs